Are New Cognitive Tests Ready For Preclinical Trials? Do Tau Tracers Track Cognitive Decline in Disease? Growth Factor Therapy: Safe in Phase 1, Awaiting Efficacy Data Clinical Trials on Alzheimer’s Disease 2013
Cloistered Retreat Takes the Pulse of BACE Research BACE—Substrates, Functions, Developmental Phenotypes Blocking BACE—Do Adult Mouse Phenotypes Predict Side Effects? Meeting Explores Complex Biology of BACE Regulation BACE Proteases in Health and Disease
Combination Trial Debate Energizes Keystone Symposium Protecting Neurons by Ramping Up Waste Disposal? Prodromal Initiative to Identify Biomarkers for Parkinson’s Researchers Build on GWAS to Parse Genetic Players in AD and PD More than 200 researchers br
Copper Mountain: Can CREB Save Memory? Copper Mountain: Knight Vision—SIRT1 Aids ADAM10, Slays Aβ Copper Mountain Brief: Rat-a-tat—New Model Comes a Knockin’ Copper Mountain: Death and Trophin Receptors—New Insight, New Drugs? Copper Mountain: Fractious R
Keystone: γ Slowly Relinquishes Its Secrets Keystone: Lipids Grease γ-Secretase Activity Keystone: Loss Versus Gain—Mutations a Drag on γ-Secretase Fiendishly complicated, γ-secretase has proved a formidable foe to the structurally minded scientist. But g
Zuers—Meeting Mixes Translational News and Debate Zuers—Αlpha, Beta, Sigma: Which Will Yield New AD Drug? Zuers—No Pill or Drip: Scientists Inject Phage Drug Into CSF Zuers—Can Spatial Navigation Guide Clinical Trials? The town of Zuers in the Austrian Al
St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function St. Louis: ApoE—Receptors, Theories and Therapies St. Louis: ApoE—A Clearer View of its Role In AD? The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease.
Therapeutic Approaches Target Deubiquitinase, Protein Turnover Paracrine Signal From BACE1-Clipped Neuregulin Rescues Myelin Could Longevity Factor, Epilepsy Med, Treat AD One Day? The small scientific workshop From Science to Therapeutics: The Best Way
Keystone: Symposium Emphasizes Key Aspects of ApoE Biology Keystone: Probing the Function of Lipoprotein and Related Receptors Keystone: ApoE Receptors and Ligands in Memory and AD Keystone: Does ApoE Fragmentation Drive Pathology? Keystone: Therapies Aro
Taos: New Neurons in New Mexico—Highlights from Keystone Taos: Disease, Drug Development, and Adult Neurogenesis It turns out you are not born with all the neurons you’ll ever need; adult neurogenesis is alive and kicking in the mammalian brain. Most nota
Keystone: Traumatic Brain Injury—Epidemiology and Characteristics Keystone: Sports-Related Injury and Chronic Traumatic Encephalopathy Keystone: Metabolic and Axonal Dysfunction in Traumatic Brain Injury Keystone: TBI—Learning From Markers, Models, and Di
San Francisco: Tweaking Brain ApoE Reduces Aβ, Symptoms San Francisco: GABA Neurons Blamed for Memory Loss in ApoE Mice Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant attent
NEALS: Collaboration for a Cure to ALS NEALS: In ALS Trials, One Design Does Not Fit All NEALS: Desperately Seeking ALS Biomarkers NEALS: Sharing Among ALS Researchers and Participants Starting on October 26, 2011, clinicians and some people with amyotrop
Colombians Come to Fore in Alzheimer’s Research, Mass Media A Neurologist’s Devotion Puts Familial AD Research Onto New Plane Detecting Familial AD Ever Earlier: Subtle Memory Signs 15 Years Before Scientists and Regulators Discuss Preclinical AD Trials C